Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Janux Therapeutics
11099 N. Torrey Pines Road, Suite 290
La Jolla, CA 92037
Phone: 858-750-4700
https://www.januxrx.com/

Janux Therapeutics is developing safe, effective novel immunotherapies with the company's proprietary TRACTr technology. Janux's TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets. The Janux TRACTr development pipeline targets multiple solid tumor indications, including colorectal, gastroesophageal, prostrate, NSCLC, triple negative breast, and ovarian cancers. Janux technology can be applied to immunotherapies that target all three stages of an anti-tumor immune response. Combining Janux's tumor-specific activation with multi-stage anti-tumor signaling has the potential to significantly improve safety, expand the therapeutic dosing window, and maximize patient responses.

Key Contact
Name
David Campbell
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/03/21 $56,000,000 Series A Avalon Ventures
Bregua Corporation
Correlation Ventures
OrbiMed Advisors
RA Capital Management
undisclosed
04/20/21 $125,000,000 Series B BVF Partners
EcoR1 Capital
Hartford HealthCare Endowment
Janus Henderson Investors
Logos Capital
RA Capital Management
Samsara BioCapital
Surveyor Capital
undisclosed


Featured Reading